3 studies found for:    17208639 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy
Condition: Gastric Cancer
Interventions: Drug: Trastuzumab;   Drug: Capecitabine;   Drug: Oxaliplatin
2 Recruiting Observation of Medical Treatments in MBC HER2-negative Patients
Condition: Metastatic Breast Cancer
Intervention: Other: Observation of treatment management
3 Active, not recruiting Trastuzumab in Treating Women With Primary Breast Cancer
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Procedure: adjuvant therapy

Indicates status has not been verified in more than two years